Skip to main content
Erschienen in: Diabetologia 6/2016

31.03.2016 | Article

Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study

verfasst von: I-Ching Chou, Chung-Hsing Wang, Wei-De Lin, Fuu-Jen Tsai, Che-Chen Lin, Chia-Hung Kao

Erschienen in: Diabetologia | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Type 1 diabetes mellitus is a major public health problem of increasing global concern, with potential neurological complications. A possible association exists between type 1 diabetes and subsequent epilepsy. This study evaluated the relationship between type 1 diabetes and epilepsy in Taiwan.

Methods

Claims data from the Taiwan National Health Insurance Research Database were used to conduct retrospective cohort analyses. The study cohort contained 2568 patients with type 1 diabetes, each of whom was frequency-matched by sex, urbanisation of residence area and index year with ten patients without type 1 diabetes. Cox proportional hazard regression analysis was conducted to estimate the effects of type 1 diabetes on epilepsy risk.

Results

In patients with type 1 diabetes, the risk of developing epilepsy was significantly higher than that in patients without type 1 diabetes (p < 0.0001 for logrank test). After adjustment for potential confounders, the type 1 diabetes cohort was 2.84 times as likely to develop epilepsy than the control cohort was (HR 2.84 [95% CI 2.11, 3.83]).

Conclusions/interpretation

Patients with type 1 diabetes are at an increased risk of developing epilepsy. Metabolic abnormalities of type 1 diabetes, such as hyperglycaemia and hypoglycaemia, may have a damaging effect on the central nervous system and be associated with significant long-term neurological sequelae. The causative factors between type 1 diabetes and the increased risk of epilepsy require further investigation.
Literatur
1.
Zurück zum Zitat Knip M, Siljander H (2008) Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7:550–557CrossRefPubMed Knip M, Siljander H (2008) Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7:550–557CrossRefPubMed
2.
Zurück zum Zitat Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381CrossRefPubMedPubMedCentral Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young—a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103:161–175CrossRefPubMed Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young—a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103:161–175CrossRefPubMed
5.
Zurück zum Zitat Kollipara S (2006) Comorbidities associated with type 1 diabetes. School Nurse News 23:42–45PubMed Kollipara S (2006) Comorbidities associated with type 1 diabetes. School Nurse News 23:42–45PubMed
6.
Zurück zum Zitat Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R (2009) Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 26:61–69CrossRefPubMed Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R (2009) Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 26:61–69CrossRefPubMed
7.
Zurück zum Zitat Moshè SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 7:884–898CrossRef Moshè SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 7:884–898CrossRef
8.
Zurück zum Zitat Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed
9.
Zurück zum Zitat Cowan LD (2002) The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 8:171–181CrossRefPubMed Cowan LD (2002) The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 8:171–181CrossRefPubMed
10.
Zurück zum Zitat Soltész G, Acsádi G (1989) Association between diabetes, severe hypo-glycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996CrossRefPubMedPubMedCentral Soltész G, Acsádi G (1989) Association between diabetes, severe hypo-glycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bergey GK (2012) Autoantibodies in the patient with drug-resistant epilepsy: are we missing a treatable etiology? Arch Neurol 69:565–566CrossRefPubMed Bergey GK (2012) Autoantibodies in the patient with drug-resistant epilepsy: are we missing a treatable etiology? Arch Neurol 69:565–566CrossRefPubMed
13.
Zurück zum Zitat McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed
14.
Zurück zum Zitat Barajas RF, Collins DE, Cha S, Geschwind MD (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage–gated potassium-channel antibody. Epilepsia 51:473–477CrossRefPubMedPubMedCentral Barajas RF, Collins DE, Cha S, Geschwind MD (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage–gated potassium-channel antibody. Epilepsia 51:473–477CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed
16.
Zurück zum Zitat Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252–258CrossRefPubMed Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252–258CrossRefPubMed
17.
Zurück zum Zitat Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti–NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti–NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed
19.
Zurück zum Zitat O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with Type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with Type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed
20.
Zurück zum Zitat Silverstein J, Klingensmith G, Copeland K et al (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186CrossRefPubMed Silverstein J, Klingensmith G, Copeland K et al (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186CrossRefPubMed
22.
Zurück zum Zitat Liu CY, Hung YT, Chuang YL et al (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 14:1–22 Liu CY, Hung YT, Chuang YL et al (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 14:1–22
23.
Zurück zum Zitat Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354CrossRefPubMed Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354CrossRefPubMed
24.
Zurück zum Zitat Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168CrossRefPubMedPubMedCentral Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101CrossRefPubMed Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101CrossRefPubMed
26.
Zurück zum Zitat Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed
27.
28.
Zurück zum Zitat Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145PubMed Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145PubMed
29.
Zurück zum Zitat Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563CrossRefPubMed Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563CrossRefPubMed
30.
Zurück zum Zitat Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B (2002) Type 1 diabetes mellitus and epilepsy partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109, E50CrossRefPubMed Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B (2002) Type 1 diabetes mellitus and epilepsy partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109, E50CrossRefPubMed
31.
Zurück zum Zitat Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735CrossRefPubMed Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735CrossRefPubMed
32.
Zurück zum Zitat Desrocher M, Rovet J (2004) Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 10:36–52CrossRefPubMed Desrocher M, Rovet J (2004) Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 10:36–52CrossRefPubMed
33.
Zurück zum Zitat Northam EA, Rankins D, Cameron FJ (2006) Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78–86CrossRefPubMed Northam EA, Rankins D, Cameron FJ (2006) Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78–86CrossRefPubMed
34.
Zurück zum Zitat Knight S, Northam E, Donath S et al (2009) Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 52:193–198CrossRefPubMed Knight S, Northam E, Donath S et al (2009) Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 52:193–198CrossRefPubMed
35.
Zurück zum Zitat Wayne EA, Dean HJ, Booth F, Tenenbein M (1990) Focal neurological deficits associated with hypoglycemia in children with diabetes. J Pediatr 117:575–577CrossRefPubMed Wayne EA, Dean HJ, Booth F, Tenenbein M (1990) Focal neurological deficits associated with hypoglycemia in children with diabetes. J Pediatr 117:575–577CrossRefPubMed
36.
Zurück zum Zitat Lahat E, Barr J, Bistritzer T (1995) Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 97:314–316CrossRefPubMed Lahat E, Barr J, Bistritzer T (1995) Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 97:314–316CrossRefPubMed
37.
Zurück zum Zitat Home P, Haddad J, Latif ZA et al (2013) Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western Countries. Diabetes Ther 4:91–102CrossRefPubMedPubMedCentral Home P, Haddad J, Latif ZA et al (2013) Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western Countries. Diabetes Ther 4:91–102CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study
verfasst von
I-Ching Chou
Chung-Hsing Wang
Wei-De Lin
Fuu-Jen Tsai
Che-Chen Lin
Chia-Hung Kao
Publikationsdatum
31.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 6/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3929-0

Weitere Artikel der Ausgabe 6/2016

Diabetologia 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.